Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
You have to log in or sign up before you can proceed.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Bioversys AG Stock

Price
Target price
€25.20

€25.20

-
-
-
-

-

 
Buy 0 Sell 0
Buy 0
Sell 0
16.12.25 / Frankfurt WKN: A410LA / Name: Bioversys / Stock / ? /
Your prediction
Pros and Cons of Bioversys AG in the next few years
Wizard

Bioversys AG Stock

What does Bioversys do?

Pros and Cons of Bioversys AG in the next few years

Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice
Register To Post

News

BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
eqs_en 
0 11.12.25
BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network
BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network
BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network
eqs_en 
0 10.11.25
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL TRIAL OF BV100 in CHInA
eqs_en 
0 06.11.25